High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,582,086
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| PTCT |
PTC THERAPEUTICS, INC.
|
Director
Other
|
2026-03-10 | $39,246 | M | Form 4 |
| PTCT |
PTC THERAPEUTICS, INC.
|
Director
10b5-1 SellΔOwn -12.7%
|
2026-03-10 | $81,690 | S | Form 4 |
| PTCT |
PTC THERAPEUTICS, INC.
|
Director
Other
|
2026-03-10 | $470,820 | M | Form 4 |
| PTCT |
PTC THERAPEUTICS, INC.
|
Director
10b5-1 SellΔOwn -63.6%
|
2026-03-10 | $980,000 | S | Form 4 |
| PTCT |
PTC THERAPEUTICS, INC.
|
Director
10b5-1 SellΔOwn -44.2%
|
2026-03-05 | $401,386 | S | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Okey Stephanie
• Director
10b5-1 SellΔOwn -18.4%
2026-03-03
$119,010
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -18.4%
|
2026-03-03 | $119,010 | S | Form 4 |